TNFSF14 and Miyoshi myopathy: Having here shown that CD14+ monocytes of MM patients experiencing therapeutic regimens express high LIGHT levels, to further explore the possible alterations within the monocytes, we investigated the percentage of circulating CD14+CD16+ cells, the key monocyte subset in the commitment of OC formation.